Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Living bibliometrics

Psilocybin and psilocin research trends

Explore how the 5,064 visible records in this index are distributed by recorded year, publication status, retained source and study type. These tables measure this bibliographic corpus, not the entire research field or treatment effectiveness.

Analysis calculated from the live index when this page is requested. The current calendar year (2026) is incomplete, and indexing delays also affect recent years. Records with future dates are shown explicitly where present.

Methods and interpretation: Dr. Christopher B. Germann · Dataset, download and reproduction guide.

Research records by year and evidence status

Year comes from the stored publication or registry date. For a trial registration it is not necessarily the study start, completion or results-publication year. “Published” is the tracker's formal-publication label; it is not an independent peer-review audit. “Other” includes reviews, protocols and any uncategorized status.

Visible records with a recorded year; 0 records without a year are excluded
YearAll recordsPublishedPreprintsTrial registrationsOther
2026 (partial year) 973723841651
2025 88873696560
2024 65454180330
2023 55045372250
2022 42336844110
2021 3042524570
2020 1701491542
2019 114107430
2018 106100510
2017 7371110
2016 6564010
2015 4141000
2014 3938010
2013 3737000
2012 2424000
2011 2222000
2010 1616000
2009 2424000
2008 2424000
2007 1616000
2006 2525000
2005 2020000
2004 1212000
2003 1818000
2002 1717000
2001 88000
2000 1717000
1999 1818000
1998 1515000
1997 44000
1996 55000
1995 11000
1994 66000
1993 66000
1992 44000
1991 11000
1990 77000
1989 66000
1988 66000
1987 66000
1986 88000
1985 66000
1984 77000
1983 44000
1982 88000
1981 1616000
1980 99000
1979 77000
1978 1010000
1977 99000
1976 77000
1975 99000
1974 1515000
1973 1515000
1972 33000
1971 99000
1970 1212000
1969 1313000
1968 1515000
1967 1212000
1966 99000
1965 1010000
1964 1010000
1963 2020000
1962 1515000
1961 1414000
1960 1111000
1959 1111000
1958 55000

Use the year links to inspect and export the underlying records. Compare completed calendar years, separate registrations and preprints, and account for backfills or curation before interpreting a change as research growth.

Source composition and identifier completeness

4,322 records (85.3%) have a DOI; 2,974 (58.7%) have a PubMed identifier. These groups overlap and must not be added. A missing DOI does not imply poor study quality; many registry records use an NCT identifier instead.

Retained primary source labels after deduplication and enrichment
SourceRecordsShare of visible corpus
PubMed2,58151.0%
OpenAlex1,17123.1%
Crossref4188.3%
ClinicalTrials.gov3086.1%
Europe PMC2324.6%
PsyArXiv1853.7%
bioRxiv1262.5%
medRxiv430.8%

Source shares describe the retained primary label, not acquisition yield or exclusive database coverage. The same work may exist in several upstream databases. OpenAlex enrichment can add identifiers or citation context while preserving a different primary source.

Study designs in the indexed literature

Study-type classifications are discovery aids derived from source metadata and screening rules. They do not evaluate bias, sample size, replication or certainty of evidence. Unclassified records are absent from this table.

Use the topic and study-type evidence map for indication-specific discovery. Use the clinical-trial tracker and recruiting-trial collection for registry status rather than inferring recruitment from a publication year.

Reproduce and interpret this analysis

Tables use visible records only: hidden and false-positive records are excluded. Each record contributes once to its stored year and status. Unknown years are counted separately. Deduplication reduces duplicate manifestations but does not guarantee that every row represents an independent study; protocols, preprints and reports can describe related work.

Download the public SQLite core and run the SQL in the dataset guide, or use the R bibliometrics toolkit. Retain the download date and file checksum. Counts can change retrospectively when older records are added or duplicates are reconciled. The fixed Zenodo v1.0.6 snapshot has a different, immutable record set.

For source selection and correction procedures see the editorial policy. For record relationships explore the citation network and author directory. These descriptive counts cannot establish clinical efficacy, safety or scientific consensus.